Influenza virus A/Anhui/1/2013 (H7N9) replicates efficiently in the upper and lower respiratory tracts of cynomolgus macaques

mBio

Volumn 5, Issue 4, 2014, Pages

  de Wit, Emmie ^a   Rasmussen, Angela L ^b   Feldmann, Friederike ^a   Bushmaker, Trenton ^a   Martellaro, Cynthia ^a   Haddock, Elaine ^a   Okumura, Atsushi ^b   Proll, Sean C ^b   Chang, Jean ^b   Gardner, Don ^a   Katze, Michael G ^b   Munster, Vincent J ^a   Feldmann, Heinz ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELL INFILTRATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; INFLUENZA VIRUS A H7N9; LOWER RESPIRATORY TRACT; LUNG ALVEOLUS CELL; LUNG INFILTRATE; MACACA FASCICULARIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; POLYMORPHONUCLEAR CELL; TISSUE INJURY; UPPER RESPIRATORY TRACT; VIRUS INFECTION; VIRUS REPLICATION; VIRUS SHEDDING; ANIMAL; AVIAN INFLUENZA; BLOOD; BRONCHUS; DOG; GENETICS; HUMAN; INFLUENZA; INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N9); LUNG; MDCK CELL LINE; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PATHOPHYSIOLOGY; PHARYNX; PHYSIOLOGY; POULTRY; RADIOGRAPHY; TRACHEA; TURBINATE; VIROLOGY; VIRUS LOAD;

MACACA; ORTHOMYXOVIRIDAE;

CYTOKINE; TRANSCRIPTOME;

ANIMALS; BRONCHI; CYTOKINES; DOGS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; LUNG; MACACA FASCICULARIS; MADIN DARBY CANINE KIDNEY CELLS; ORTHOMYXOVIRIDAE INFECTIONS; PHARYNX; POULTRY; TRACHEA; TRANSCRIPTOME; TURBINATES; VIRAL LOAD; VIRUS REPLICATION;

EID: 84908302464     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01331-14     Document Type: Article

References (60)

1. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368:1888-1897. http://dx.doi.org/10.1056/NEJMoa1304459.
2. WHO. 2014. Confirmed human cases of avian influenza A(H7N9) reported to WHO. World Health Organization, Geneva, Switzerland. http://www.who.int/influenza/human_animal_interface/influenza_h7n9/13_ReportWebH7N9Number_20140221.pdf.
3. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, Lu SH, Yang YD, Fang Q, Shen YZ, Xi XM, Gu Q, Zhou XM, Qu HP, Yan Z, Li FM, Zhao W, Gao ZC, Wang GF, Ruan LX, Wang WH, Ye J, Cao HF, Li XW, Zhang WH, Fang XC, He J, Liang WF, Xie J, Zeng M, Wu XZ, Li J, Xia Q, Jin ZC, Chen Q, Tang C, Zhang ZY, Hou BM, Feng ZX, Sheng JF, Zhong NS, Li LJ. 2013. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N. Engl. J. Med. 368:2277-2285. http://dx.doi.org/10.1056/NEJMoa1305584.
4. Yu L, Wang Z, Chen Y, Ding W, Jia H, Chan JF, To KK, Chen H, Yang Y, Liang W, Zheng S, Yao H, Yang S, Cao H, Dai X, Zhao H, Li J, Bao Q, Chen P, Hou X, Li L, Yuen KY. 2013. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin. Infect. Dis. 57:1449-1457. http://dx.doi.org/10.1093/cid/cit541.
5. Belser JA, Bridges CB, Katz JM, Tumpey TM. 2009. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg. Infect. Dis. 15:859-865. http://dx.doi.org/10.3201/eid1506.090072.
6. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. U. S. A. 101:1356-1361. http://dx.doi.org/10.1073/pnas.0308352100.
7. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, Uchida Y, Neumann G, Saito T, Kawaoka Y, Tashiro M. 2013. Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill. 18:20453.
8. Lam TT, Wang J, Shen Y, Zhou B, Duan L, Cheung CL, Ma C, Lycett SJ, Leung CY, Chen X, Li L, Hong W, Chai Y, Zhou L, Liang H, Ou Z, Liu Y, Farooqui A, Kelvin DJ, Poon LL, Smith DK, Pybus OG, Leung GM, Shu Y, Webster RG, Webby RJ, Peiris JS, Rambaut A, Zhu H, Guan Y. 2013. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 502:241-244. http://dx.doi.org/10.1038/nature12515.
9. Liu Q, Lu L, Sun Z, Chen GW, Wen Y, Jiang S. 2013. Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China. Microbes Infect. 15:432-439. http://dx.doi.org/10.1016/j.micinf.2013.04.004.
10. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, Sun X, Carney PJ, Villanueva JM, Stevens J, Katz JM, Tumpey TM. 2013. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501:556-559. http://dx.doi.org/10.1038/nature12391.
11. Richard M, Schrauwen EJ, de Graaf M, Bestebroer TM, Spronken MI, van Boheemen S, de Meulder D, Lexmond P, Linster M, Herfst S, Smith DJ, van den Brand JM, Burke DF, Kuiken T, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2013. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501:560-563. http://dx.doi.org/10.1038/nature12476.
12. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, Takashita E, McBride R, Noda T, Hatta M, Imai H, Zhao D, Kishida N, Shirakura M, de Vries RP, Shichinohe S, Okamatsu M, Tamura T, Tomita Y, Fujimoto N, Goto K, Katsura H, Kawakami E, Ishikawa I, Watanabe S, Ito M, Sakai-Tagawa Y, Sugita Y, Uraki R, Yamaji R, Eisfeld AJ, Zhong G, Fan S, Ping J, Maher EA, Hanson A, Uchida Y, Saito T, Ozawa M, Neumann G, Kida H, Odagiri T, Paulson JC, Hasegawa H, Tashiro M, Kawaoka Y. 2013. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551-555. http://dx.doi.org/10.1038/nature12392.
13. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, Wong SS, Farooqui A, Wang J, Banner D, Chen R, Zheng R, Zhou J, Zhang Y, Hong W, Dong W, Cai Q, Roehrl MH, Huang SS, Kelvin AA, Yao T, Zhou B, Chen X, Leung GM, Poon LL, Webster RG, Webby RJ, Peiris JS, Guan Y, Shu Y. 2013. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341: 183-186. http://dx.doi.org/10.1126/science.1239844.
14. O’Donnell CD, Subbarao K. 2011. The contribution of animal models to the understanding of the host range and virulence of influenza A viruses. Microbes Infect. 13:502-515. http://dx.doi.org/10.1016/j.micinf.2011.01.014.
15. Siegers JY, Short KR, Leijten LM, de Graaf M, Spronken MI, Schrauwen EJ, Marshall N, Lowen AC, Gabriel G, Osterhaus AD, Kuiken T, van Riel D. 2014. Novel avian-origin influenza A (H7N9) virus attachment to the respiratory tract of five animal models. J. Virol. 88:4595-4599. http://dx.doi.org/10.1128/JVI.03190-13.
16. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, Gardner D, Proll SC, Marzi A, Tsuda Y, Lacasse RA, Kercher L, York A, Korth MJ, Long D, Rosenke R, Shupert WL, Aranda CA, Mattoon JS, Kobasa D, Kobinger G, Li Y, Taubenberger JK, Richt JA, Parnell M, Ebihara H, Kawaoka Y, Katze MG, Feldmann H. 2011. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J. Virol. 85:1214-1223. http://dx.doi.org/10.1128/JVI.01848-10.
17. Richt JA, Rockx B, Ma W, Feldmann F, Safronetz D, Marzi A, Kobasa D, Strong JE, Kercher L, Long D, Gardner D, Brining D, Feldmann H. 2012. Recently emerged swine influenza A virus (H2N3) causes severe pneumonia in cynomolgus macaques. PLoS One 7:e39990. http://dx.doi.org/10.1371/journal.pone.0039990.
18. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, García-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, Aicher LD, Rosenzweig ER, Murali-Krishna K, Clark EA, Kotur MS, Fornek JL, Proll S, Palermo RE, Sabourin CL, Katze MG. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. U. S. A. 106:3455-3460. http://dx.doi.org/10.1073/pnas.0813234106.
19. Go JT, Belisle SE, Tchitchek N, Tumpey TM, Ma W, Richt JA, Safronetz D, Feldmann H, Katze MG. 2012. 2009 pandemic H1N1 influenza virus elicits similar clinical course but differential host transcriptional response in mouse, macaque, and swine infection models. BMC Genomics 13:627. http://dx.doi.org/10.1186/1471-2164-13-627.
20. Josset L, Engelmann F, Haberthur K, Kelly S, Park B, Kawoaka Y, García-Sastre A, Katze MG, Messaoudi I. 2012. Increased viral loads and exacerbated innate host responses in aged macaques infected with the 2009 pandemic H1N1 influenza A virus. J. Virol. 86:11115-11127. http://dx.doi.org/10.1128/JVI.01571-12.
21. Shoemaker JE, Fukuyama S, Eisfeld AJ, Muramoto Y, Watanabe S, Watanabe T, Matsuoka Y, Kitano H, Kawaoka Y. 2012. Integrated network analysis reveals a novel role for the cell cycle in 2009 pandemic influenza virus-induced inflammation in macaque lungs. BMC Syst. Biol. 6:117. http://dx.doi.org/10.1186/1752-0509-6-117.
22. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. 2006. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-1935. http://dx.doi.org/10.1126/science.1132939.
23. Guerrero CA, Murillo A, Acosta O, Acosta O. 2012. Inhibition of rotavirus infection in cultured cells by N-acetyl-cysteine, PPARgamma agonists and NSAIDs. Antiviral Res. 96:1-12. http://dx.doi.org/10.1016/j.antiviral.2012.06.011.
24. Wakui Y, Inoue J, Ueno Y, Fukushima K, Kondo Y, Kakazu E, Obara N, Kimura O, Shimosegawa T. 2010. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone. Biochem. Biophys. Res. Commun. 396:508-514. http://dx.doi.org/10.1016/j.bbrc.2010.04.128.
25. Kim K, Kim KH, Ha E, Park JY, Sakamoto N, Cheong J. 2009. Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma. FEBS Lett. 583:2720-2726. http://dx.doi.org/10.1016/j.febslet.2009.07.034.
26. Huang W, Rha GB, Han MJ, Eum SY, András IE, Zhong Y, Hennig B, Toborek M. 2008. PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. J. Neurochem. 107:497-509. http://dx.doi.org/10.1111/j.1471-4159.2008.05626.x.
27. Ramirez SH, Heilman D, Morsey B, Potula R, Haorah J, Persidsky Y. 2008. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes. J. Immunol. 180:1854-1865. http://dx.doi.org/10.4049/jimmunol.180.3.1854.
28. Liu DS, Liu WJ, Chen L, Ou XM, Wang T, Feng YL, Zhang SF, Xu D, Chen YJ, Wen FQ. 2009. Rosiglitazone, a peroxisome proliferatoractivated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats. Toxicology 260:112-119. http://dx.doi.org/10.1016/j.tox.2009.03.016.
29. Zhu M, Flynt L, Ghosh S, Mellema M, Banerjee A, Williams E, Panettieri RA, Jr, Shore SA. 2011. Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 45:111-119. http://dx.doi.org/10.1165/rcmb.2009-0445OC.
30. Lee KS, Park SJ, Kim SR, Min KH, Jin SM, Lee HK, Lee YC. 2006. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma. J. Immunol. 177:5248-5257. http://dx.doi.org/10.4049/jimmunol.177.8.5248.
31. Chen W, Sharma R, Rizzo AN, Siegler JH, Garcia JG, Jacobson JR. 2014. Role of claudin-5 in the attenuation of murine acute lung injury by simvastatin. Am. J. Respir. Cell Mol. Biol. 50:328-336. http://dx.doi.org/10.1165/rcmb.2013-0058OC.
32. Jin Y, Tachibana I, Takeda Y, He P, Kang S, Suzuki M, Kuhara H, Tetsumoto S, Tsujino K, Minami T, Iwasaki T, Nakanishi K, Kohmo S, Hirata H, Takahashi R, Inoue K, Nagatomo I, Kida H, Kijima T, Ito M, Saya H, Kumanogoh A. 2013. Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages. PLoS One 8:e73706. http://dx.doi.org/10.1371/journal.pone.0073706.
33. Davis BB, Zeki AA, Bratt JM, Wang L, Filosto S, Walby WF, Kenyon NJ, Goldkorn T, Schelegle ES, Pinkerton KE. 2013. Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy. Eur. Respir. J. 42:350-361. http://dx.doi.org/10.1183/09031936.00042512.
34. Zeki AA, Thai P, Kenyon NJ, Wu R. 2012. Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells. Respir. Res. 13:38. http://dx.doi.org/10.1186/1465-9921-13-38.
35. Wu BQ, Luo JM, Wang YH, Shi YF, Liu H, Ba JH, Zhang TT. 2014. Inhibitory effects of simvastatin on Staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages. Clin. Exp. Med. 14:151-160. http://dx.doi.org/10.1007/s10238-013-0231-z.
36. Boyd AR, Hinojosa CA, Rodriguez PJ, Orihuela CJ. 2012. Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia. BMC Microbiol. 12:73. http://dx.doi.org/10.1186/1471-2180-12-73.
37. McDowell SA, Ma Y, Kusano R, Akinbi HT. 2011. Simvastatin is protective during Staphylococcus aureus pneumonia. Curr. Pharm. Biotechnol. 12:1455-1462. http://dx.doi.org/10.2174/138920111798281027.
38. Belser JA, Szretter KJ, Katz JM, Tumpey TM. 2013. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice. Virology 439:42-46. http://dx.doi.org/10.1016/j.virol.2013.01.017.
39. Glück B, Schmidtke M, Walther M, Meerbach A, Wutzler P. 2013. Simvastatin treatment showed no prophylactic effect in influenza virusinfected mice. J. Med. Virol. 85:1978-1982. http://dx.doi.org/10.1002/jmv.23682.
40. Kumaki Y, Morrey JD, Barnard DL. 2012. Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice. Future Virol. 7:801-818. http://dx.doi.org/10.2217/fvl.12.71.
41. van Riel D, Leijten LM, de Graaf M, Siegers JY, Short KR, Spronken MI, Schrauwen EJ, Fouchier RA, Osterhaus AD, Kuiken T. 2013. Novel avian-origin influenza A (H7N9) virus attaches to epithelium in both upper and lower respiratory tract of humans. Am. J. Pathol. 183: 1137-1143. http://dx.doi.org/10.1016/j.ajpath.2013.06.011.
42. Chan MCW, Chan RWY, Chan LLY, Mok CKP, Hui KPY, Fong JHM, Tao KP, Poon LL, Nicholls JM, Peiris JS. 2013. Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir. Med. 1:534-542. http://dx.doi.org/10.1016/S2213-2600(13)70138-3.
43. Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, Zhang X, Yen HL, Shi B, Li T, Guan W, Xu L, Liu Y, Wang S, Tian D, Zhu Z, He J, Huang K, Chen H, Zheng L, Li X, Ping J, Kang B, Xi X, Zha L, Li Y, Zhang Z, Peiris M, Yuan Z, Yuan Z. 2013. Association between adverse clinical outcome in human disease caused by novel influenzaAH7N9virus and sustained viral shedding and emergence of antiviral resistance. Lancet 381:2273-2279. http://dx.doi.org/10.1016/S0140-6736(13)61125-3.
44. Sleeman K, Guo Z, Barnes J, Shaw M, Stevens J, Gubareva LV. 2013. R292K substitution and drug susceptibility of influenza A(H7N9) viruses. Emerg. Infect. Dis. 19:1521-1524. http://dx.doi.org/10.3201/eid1909.130724.
45. Yen HL, McKimm-Breschkin JL, Choy KT, Wong DD, Cheung PP, Zhou J, Ng IH, Zhu H, Webby RJ, Guan Y, Webster RG, Peiris JS. 2013. Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population. mBio 4:e00396-13. http://dx.doi.org/10.1128/mBio.00396-13.
46. Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, Carter VS, Yount BL, Graham RL, Baric RS, Katze MG. 2013. Cell host response to infection with novel human coronavirusEMCpredicts potential antivirals and important differences with SARS coronavirus. mBio 4:e00165-13. http://dx.doi.org/10.1128/mBio.00165-13.
47. Herfst S, van den Brand JM, Schrauwen EJ, de Wit E, Munster VJ, van Amerongen G, Linster M, Zaaraoui F, van Ijcken WF, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Andeweg AC, Kuiken T. 2010. Pandemic 2009 H1N1 influenza virus causes diffuse alveolar damage in cynomolgus macaques. Vet. Pathol. 47:1040-1047. http://dx.doi.org/10.1177/0300985810374836.
48. Rimmelzwaan GF, Baars M, van Beek R, van Amerongen G, Lovgren-Bengtsson K, Claas EC, Osterhaus AD. 1997. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J. Gen. Virol. 78:757-765.
49. Kobayashi SD, Olsen RJ, Lacasse RA, Safronetz D, Ashraf M, Porter AR, Braughton KR, Feldmann F, Clifton DR, Kash JC, Bailey JR, Gardner DJ, Otto M, Brining DL, Kreiswirth BN, Taubenberger JK, Parnell MJ, Feldmann H, Musser JM, Deleo FR. 2013. Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model. Virulence 4:707-715. http://dx.doi.org/10.4161/viru.26572.
50. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, Feldmann F, Alimonti JB, Fernando L, Li Y, Katze MG, Feldmann H, Kawaoka Y. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445:319-323. http://dx.doi.org/10.1038/nature05495.
51. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD. 2001. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol. 75:6687-6691. http://dx.doi.org/10.1128/JVI.75.14.6687-6691.2001.
52. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. 1994. Receptor specificity in human, avian, and equineH2andH3influenza virus isolates. Virology 205:17-23. http://dx.doi.org/10.1006/viro.1994.1615.
53. Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, Donatelli I, Kawaoka Y. 2000. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 74: 8502-8512. http://dx.doi.org/10.1128/JVI.74.18.8502-8512.2000.
54. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solórzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, García-Sastre A. 2007.Atwo-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659. http://dx.doi.org/10.1126/science.1136212.
55. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, Gustin KM, Pearce MB, Viswanathan K, Shriver ZH, Raman R, Cox NJ, Sasisekharan R, Katz JM, Tumpey TM. 2009. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325:484-487. http://dx.doi.org/10.1126/science.1177238.
56. Watanabe T, Shinya K, Watanabe S, Imai M, Hatta M, Li C, Wolter BF, Neumann G, Hanson A, Ozawa M, Yamada S, Imai H, Sakabe S, Takano R, Iwatsuki-Horimoto K, Kiso M, Ito M, Fukuyama S, Kawakami E, Gorai T, Simmons HA, Schenkman D, Brunner K, Capuano SV III, Weinfurter JT, Nishio W, Maniwa Y, Igarashi T, Makino A, Travanty EA, Wang J, Kilander A, Dudman SG, Suresh M, Mason RJ, Hungnes O, Friedrich TC, Kawaoka Y. 2011. Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J. Virol. 85:13195-13203. http://dx.doi.org/10.1128/JVI.00859-11.
57. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541. http://dx.doi.org/10.1126/science.1213362.
58. Brining DL, Mattoon JS, Kercher L, LaCasse RA, Safronetz D, Feldmann H, Parnell MJ. 2010. Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis). Comp. Med. 60:389-395.
59. Munster VJ, Baas C, Lexmond P, Bestebroer TM, Guldemeester J, Beyer WE, de Wit E, Schutten M, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2009. Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J. Clin. Microbiol. 47:666-673. http://dx.doi.org/10.1128/JCM.01625-08.
60. Karber G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuch [A contribution to the collective treatment of pharmacological experimental series]. Arch. Exp. Pathol. Pharmakologie 162: 480-483. http://dx.doi.org/10.1007/BF01863914.